[1] Li Y, Huang YS, Wang ZZ, et al.Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Therap,2016,43:458-469.
[2] Petitclerc L, Sebastiani G, Gilbert G, et al.Liver fibrosis: Review of current imaging and MRI quantification techniques. J Magn Reson Imaging,2017,45:1276-1295.
[3] Hu X, Qiu L, Liu D, et al.Acoustic radiation force impulse (ARFI) elastography for noninvasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis. Med Ultrasonog,2017,19:23-31.
[4] Cui XW, Friedrich-Rust M, De Molo C, et al.Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol,2013,19:6329-6347.
[5] Van Beers BE, Daire JL, Garteiser P.New imaging techniques for liver diseases. J Hepatol,2015,62:690-700.
[6] Kim S, Shuman WP.Clinical applications of dual-energy computed tomography in the liver. Semin Roentgenol,2016,51:284-291.
[7] Li JP, Feng GL, Li DQ,et al.Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model. Hepatobiliary Pancreatic Dis Int,2016,15:612-618.
[8] Vandecaveye V, Michielsen K, De Keyzer F, et al.Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. Radiology,2014,270:747-757.
[9] Hu G, Chan Q, Quan X, et al.Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model. J Magn Reson Imaging,2015,42:331-339.
[10] Wang YXJ, Deng M, Li YT, et al.A combined use of intravoxel incoherent motion MRI parameters can differentiate early-stage hepatitis-B fibrotic livers from healthy livers. SLAS Technol,2017:2472630317717049.
[11] Lee Y, Lee SS, Kim N, et al.Intravoxel incoherent motion diffusion-weighted MR imaging of the liver: effect of triggering methods on regional variability and measurement repeatability of quantitative parameters. Radiology,2015,274:405-415.
[12] Lagadec M, Doblas S, Giraudeau C, et al.Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. Radiology,2015,274:379-386.
[13] Bastati N, Feier D, Wibmer A, et al.Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. Radiology,2014,271:739-747.
[14] Wibmer A, Prusa AM, Nolz R, et al.Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology,2013,269:777-786.
[15] Donato H, Franca M, Candelaria I, et al.Liver MRI: From basic protocol to advanced techniques. Eur J Radiol,2017,93:30-39.
[16] Guo Y, Parthasarathy S, Goyal P, et al.Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging,2015,40:818-834.
[17] Singh S, Venkatesh SK, Loomba R, et al.Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol,2016,26:1431-1440. |
